Gabapentin Use Skyrockets Despite Risks, CDC Analysis Shows

By News Health
17 hours Ago

(MedPage Today) — Gabapentin prescribing rose sharply in recent years, with the generic drug becoming the fifth most dispensed product in retail pharmacies in 2024, a CDC analysis showed.
From 2010 to 2024, prescriptions jumped from 79.5 to 177…

Source link : https://www.medpagetoday.com/neurology/generalneurology/117705

Author :

Publish date : 2025-09-29 21:43:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Biologics May Promote Structural Lung Changes in COPD

Dolly Parton's Health Concern; HHS to Furlough 41% of Workers? Tylenol Lawsuit Boost

Trump's Remarks on Autism Evoke Anger and Hope in Autistic People and Their Families

Patient Dialogues: Inflammation and Dietary Interventions

Clean Air, Green Spaces May Guard Kids Against Hypertension

Covid cases rising with new variants 'Nimbus' and 'Stratus'